Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1600 of 3284 entries
View as:

Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)

Phase: N/A Priority: Normal
NCT ID: NCT00396110 Org: User:
Start: 02/28/03 End: - Due: -

Management of Cardiovascular Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT00848380 Org: User:
Start: 02/28/09 End: 12/31/09 Due: 12/31/10

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

Phase: N/A Priority: Normal
NCT ID: NCT01096017 Org: User:
Start: 03/31/10 End: 04/30/10 Due: 04/30/11

A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02681094 Org: User:
Start: 02/26/16 End: 07/15/17 Due: 07/15/18

Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04686591 Org: User:
Start: 12/21/20 End: 02/04/21 Due: 02/04/22

Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00672490 Org: User:
Start: 04/30/08 End: 07/31/09 Due: 07/31/10

Assessment of the Effect of Food on ABT-143 Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT00719693 Org: User:
Start: 07/31/08 End: - Due: -

An Interaction Study of Ketoconazole/Verapamil Versus AZD1305

Phase: N/A Priority: Normal
NCT ID: NCT00707551 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00372853 Org: User:
Start: 11/30/06 End: 05/31/10 Due: 05/31/11

AZD5672 Absolute Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT00746837 Org: User:
Start: 08/31/08 End: 01/31/09 Due: 01/31/10

Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities

Phase: N/A Priority: Normal
NCT ID: NCT01325948 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

Phase: N/A Priority: Normal
NCT ID: NCT02783573 Org: User:
Start: 07/01/16 End: 09/28/18 Due: 09/28/19

AZD8075 Single Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00787072 Org: User:
Start: 10/31/08 End: 01/31/09 Due: 01/31/10

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01151215 Org: User:
Start: 06/30/10 End: 01/31/13 Due: 01/31/14

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00935532 Org: User:
Start: 07/31/09 End: 07/31/11 Due: 07/31/12

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT01000896 Org: User:
Start: 01/31/10 End: 03/31/11 Due: 03/31/12

Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal

Phase: N/A Priority: Normal
NCT ID: NCT00781560 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02568397 Org: User:
Start: 10/31/15 End: 01/31/16 Due: 01/31/17

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

Phase: N/A Priority: Normal
NCT ID: NCT00641680 Org: User:
Start: 04/30/03 End: 07/31/03 Due: 07/31/04

CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

Phase: N/A Priority: Normal
NCT ID: NCT02230241 Org: User:
Start: 09/30/14 End: 11/30/15 Due: 11/30/16

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00633269 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06491550 Org: User:
Start: 07/15/24 End: 06/11/25 Due: 06/11/26

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Phase: N/A Priority: Normal
NCT ID: NCT03459846 Org: User:
Start: 03/16/18 End: 12/31/25 Due: 12/31/26

Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

Phase: N/A Priority: Normal
NCT ID: NCT00914342 Org: User:
Start: 07/31/09 End: 12/31/09 Due: 12/31/10

Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118

Phase: N/A Priority: Normal
NCT ID: NCT01533155 Org: User:
Start: 03/31/12 End: 09/30/12 Due: 09/30/13